CPE reports higher August revenue for Charoen Pokphand Enterprise Taiwan stock

Published on 10/01/2026 at 11:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CPE revenue rose to TWD 2.36 billion in August from TWD 2.33 billion. Charoen Pokphand Enterprise Taiwan stock follows EBIT growth of 55.64 percent.

CPE, TW0001215002, Illustration mit AI erstellt.

CPE reported higher August revenue while Charoen Pokphand Enterprise Taiwan stock remains tied to a stronger operating picture. Revenue reached TWD 2.36 billion in August 2026, up from TWD 2.33 billion in August 2025, according to TradingView on September 9, 2026.

Revenue growth reaches Taiwan operations

The monthly increase was modest at 1.31 percent, but the year-to-date comparison was stronger. January-to-August revenue rose to TWD 19.33 billion from TWD 18.46 billion in the same period of 2025, an increase of 4.69 percent.

The figures cover Charoen Pokphand Enterprise Taiwan Co., Ltd., a Taiwan-based food-products group whose activities include animal feed, meat processing, prepared foods and eggs. The revenue trend gives the stock a more constructive operating reference than the single-month comparison alone.

Profitability is the larger signal

Eulerpool listed EBIT at TWD 3.95 billion as of September 23, 2026, compared with TWD 2.54 billion previously. That represents growth of 55.64 percent, a larger improvement than the 4.69 percent increase in January-to-August revenue.

The gap between sales growth and operating-profit growth is the key point for investors. It indicates that the earnings picture depends not only on volumes, but also on product mix, operating costs and the contribution from higher-margin activities.

Stock valuation remains range-bound

On the Taiwan Stock Exchange, the stock was trading at TWD 105.50 on October 1, 2026 at 1:30 p.m. TST, versus a previous close of TWD 105.00. The same-day market data placed market capitalization at TWD 31.1 billion and the 52-week range at TWD 100.50 to TWD 163.50.

The distance between the current quote and the 52-week high shows that the earnings improvement has not translated into a return to the top of the annual range. For investors, the next test is whether the stronger EBIT trend can persist alongside continued revenue growth.